BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28711323)

  • 41. Transcatheter Aortic Valve Replacement and MitraClip to Reverse Heart Failure.
    Basra S; Szerlip M
    Interv Cardiol Clin; 2017 Jul; 6(3):373-386. PubMed ID: 28600091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of surgical aortic valve replacement and transapical transcatheter aortic valve replacement in patients with previous coronary artery bypass grafting.
    Onorati F; D'Onofrio A; Biancari F; Salizzoni S; De Feo M; Agrifoglio M; Mariscalco G; Lucchetti V; Messina A; Musumeci F; Santarpino G; Esposito G; Santini F; Magagna P; Beghi C; Aiello M; Ratta ED; Savini C; Troise G; Cassese M; Fischlein T; Glauber M; Passerone G; Punta G; Juvonen T; Alfieri O; Gabbieri D; Mangino D; Agostinelli A; Livi U; Di Gregorio O; Minati A; Rinaldi M; Gerosa G; Faggian G;
    Interact Cardiovasc Thorac Surg; 2016 Jun; 22(6):806-12. PubMed ID: 26979656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Outcomes After Transapical and Transfemoral Transcatheter Aortic Valve Insertion: An Evolving Experience.
    Murashita T; Greason KL; Pochettino A; Sandhu GS; Nkomo VT; Bresnahan JF; Reeder GS; Holmes DR; Rihal CS; Mathew V
    Ann Thorac Surg; 2016 Jul; 102(1):56-61. PubMed ID: 27112646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discussion.
    J Thorac Cardiovasc Surg; 2017 Oct; 154(4):1231-1232. PubMed ID: 28712583
    [No Abstract]   [Full Text] [Related]  

  • 45. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State.
    Hannan EL; Samadashvili Z; Jordan D; Sundt TM; Stamato NJ; Lahey SJ; Gold JP; Wechsler A; Ashraf MH; Ruiz C; Wilson S; Smith CR
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002744. PubMed ID: 26227347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcatheter Aortic Valve Replacement: The Good Results of the New Generation of Transcatheter Aortic Valve Replacement Devices Are Confirmed.
    Vahanian A; Himbert D
    JACC Cardiovasc Interv; 2016 Feb; 9(4):385-386. PubMed ID: 26892085
    [No Abstract]   [Full Text] [Related]  

  • 48. Transapical Transcatheter Closure of the Pseudoaneurysm in the Left Ventricular Outflow Tract After Aortic Valve Replacement.
    Katada Y; Ito J; Shibayama K; Nakatsuka D; Kawano Y; Watanabe H; Tabata M
    JACC Cardiovasc Interv; 2016 Sep; 9(18):e181-3. PubMed ID: 27592012
    [No Abstract]   [Full Text] [Related]  

  • 49. Simultaneous double valve-in-valve TAVI procedure for failed bioprostheses.
    Schlömicher M; Haldenwang PL; Moustafine V; Bechtel M; Strauch JT
    Ann Thorac Surg; 2015 Feb; 99(2):722-4. PubMed ID: 25639426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous repair of left ventricular pseudoaneurysm after transcatheter aortic valve replacement.
    Mendiz O; Fava C; Cerda M; Lev G; Caponi G; Valdivieso L
    Cardiovasc Revasc Med; 2017 Sep; 18(6S1):30-31. PubMed ID: 28262477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Art and Science of Cerebrovascular Event Prevention After Transcatheter Aortic Valve Replacement.
    Dangas GD; Giustino G
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27601430
    [No Abstract]   [Full Text] [Related]  

  • 52. Implementing the Transcatheter Aortic Valve Replacement Heart Team: Complementary, Not Competitive, to Surgical Aortic Valve Replacement Volume and Outcomes.
    Lou X; Forcillo J; Thourani VH
    Semin Thorac Cardiovasc Surg; 2016; 28(2):361-362. PubMed ID: 28043444
    [No Abstract]   [Full Text] [Related]  

  • 53. Utilization and Mortality Trends in Transcatheter and Surgical Aortic Valve Replacement: The New York State Experience--2011 to 2012.
    Hermiller J; Sampson AJ
    JACC Cardiovasc Interv; 2016 Mar; 9(6):586-8. PubMed ID: 27013158
    [No Abstract]   [Full Text] [Related]  

  • 54. Transcatheter Aortic Valve Replacement in Low-Flow Aortic Stenosis: Treat the Flow or Treat the Patient?
    Raissi SR; Thomas JD; Bonow RO
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654200
    [No Abstract]   [Full Text] [Related]  

  • 55. The Results of Transcatheter Aortic Valve Replacement Continue to Improve: The Specific Example of a Self-Expandable Transcatheter Heart Valve in a Real-Life Registry.
    Vahanian A; Urena M
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2099-2100. PubMed ID: 29050628
    [No Abstract]   [Full Text] [Related]  

  • 56. Transcatheter aortic valve implantation: the transaortic approach.
    Chow SC; Cheung GS; Lee AP; Wu EB; Ho JY; Kwok MW; Yu PS; Wan IY; Underwood MJ; Wong RH
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):357-363. PubMed ID: 28513189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report.
    Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrovascular Events With Transcatheter Aortic Valve Replacement: Can We Identify Those Who Are at Risk?
    Bavry AA; Elgendy IY
    J Am Coll Cardiol; 2016 Aug; 68(7):685-7. PubMed ID: 27515326
    [No Abstract]   [Full Text] [Related]  

  • 60. Repeated transapical TAVI for the treatment of a degenerated bioprosthetic valve.
    Eftychiou C; Kokkinos C; Evangelakis E; Houri S; Simamonian K; Yiannikourides V; Maimaris M; Cassese M
    Hellenic J Cardiol; 2018; 59(1):40-42. PubMed ID: 28803988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.